The Unspoken Problem with Head and Neck Cancer.
Although few statistics are available to assess how patients with cancer are affected by prescription opioid use, a recent study found that 70% of patients with cancer use opiates after radiation, according to a poster presented at the ASCO 2018 Palliative and Supportive Care in Oncology Symposium.
Moreover, the researchers found higher rates of use among patients who received chemotherapy, actively smoked, used alcohol, or were diagnosed with head and neck cancer, while cancer survivors who were treated with radiation for more than 4 weeks had high rates of opiate use 1 year after finishing treatment. Read more...
Study supports weekly low-dose cisplatin for advanced head and neck squamous cell carcinoma
Patients with locally advanced head and neck squamous cell carcinoma who received weekly low-dose cisplatin with concurrent radiotherapy achieved the same survival as those who received standard high-dose cisplatin every 3 weeks plus radiotherapy, according to study results published in Journal of the National Cancer Institute.
However, patients who received the low-dose weekly regimen — commonly used in the United States — experienced considerably less toxicity.
A Personal HPV Story: Former Senator Norm Coleman
Former Minnesota Senator Norm Coleman is sharing a message of strength and awareness during his second battle with cancer, reported CBS Minnesota.
Three and a half years ago Coleman underwent chemo, radiation, and surgery to kill the cancer in his tonsil and neck.